Author:
Arthur Gertrude,Ahmed Nermin,Nichols Kellea,Poupeau Audrey,Collins Katelyn,Lindner Volkhard,Loria Analia
Abstract
ABSTRACTIncreased circulating levels of the soluble prorenin receptor (sPRR), a component of the renin angiotensin system (RAS), plays a role in obesity, glucose, and insulin homeostasis. However, elevated plasma sPRR in diabetic patients has been shown correlated with hyperglycemia in women but not men. Hence, the current study sought to understand the contribution of human sPRR (HsPRR) produced in the adipose tissue (Adi) on adipogenesis, and glucose and insulin balance in obesity settings. Adi-HsPRR mice were generated by breeding human sPRR-Myc-tag transgenic mice with mice expressing Adiponectin/Cre. The mouse model was validated by detecting 28kDa myc-tagged HsPRR by western blotting. Adipose HsPRR expression did not change circulating sPRR in female mice fed a standard chow diet or high fat diet (HFD) but increased plasma sPRR in male Adi-HsPRR mice fed a HFD compared to HFD-fed controls. Yet, Adi-HsPRR improved insulin sensitivity, vascular relaxation and the vasodilator agent Ang 1-7 in obese female mice but not in the male counterparts. Moreover, Adi-HsPRR expression reduced the expression of the adipogenic genes SREBP1C and CD36 only in gonadal white adipose from obese female mice, signifying that adipose tissue-derived HsPRR exerts a sex-specific effect on insulin sensitivity and endothelial function which seems independent of circulating sPRR.
Publisher
Cold Spring Harbor Laboratory
Reference47 articles.
1. Organization WH. Obesity and overweight https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight2021 [Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
2. Steirman B . National Health and Nutrition Examination Survey 2017 - March 2020 prepandemic data files : development of files and prevalence estimates for selected health outcomes. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2021.
3. Hall ME , Cohen JB , Ard JD , Egan BM , Hall JE , Lavie CJ , et al. Weight-Loss Strategies for Prevention and Treatment of Hypertension: A Scientific Statement From the American Heart Association. Hypertension. 2021;78(5).
4. Obesity-related hypertension: a review of pathophysiology, management, and the role of metabolic surgery;Gland Surgery,2020
5. Obesity and hypertension;Experimental and Therapeutic Medicine,2016